We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IGC market cap is 28.25M. The company's latest EPS is USD -0.1679 and P/E is -2.14.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 291k | 204k | 295k | 272k | 412k |
| Operating Income | -2.49M | -5.62M | -2.89M | -2.4M | -1.76M |
| Net Income | -2.45M | -5.59M | -2.89M | -2.38M | -1.72M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.07M | 898k | 397k | 911k | 1.35M |
| Operating Income | -6.86M | -8.72M | -15.43M | -11.57M | -13.14M |
| Net Income | -7.32M | -8.81M | -15.02M | -11.51M | -13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.51M | 11.26M | 9.9M | 10.59M | 10.37M |
| Total Liabilities | 2.41M | 2.21M | 2.58M | 2.71M | 2.99M |
| Total Equity | 14.1M | 9.05M | 7.32M | 7.88M | 7.38M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.98M | 35.87M | 26.83M | 17.18M | 9.9M |
| Total Liabilities | 2.45M | 3.06M | 2.94M | 2.27M | 2.58M |
| Total Equity | 26.54M | 32.8M | 23.89M | 14.91M | 7.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.09M | -4.67M | -5.2M | -1.75M | -2.75M |
| Investing | 67k | 6k | -317k | -131k | -196k |
| Financing | 2.86M | 2.86M | 3.52M | 2.51M | 3.3M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.68M | -10.8M | -7.46M | -7.05M | -5.2M |
| Investing | -9.55M | 3.39M | -742k | -235k | -317k |
| Financing | -59k | 14.69M | 4.14M | 100k | 3.52M |
| Market Cap | 28.25M |
| Price to Earnings Ratio | -2.14 |
| Price to Sales Ratio | 20.69 |
| Price to Cash Ratio | 23.23 |
| Price to Book Ratio | 3.81 |
| Dividend Yield | - |
| Shares Outstanding | 77.45M |
| Average Volume (1 week) | 365.16k |
| Average Volume (1 Month) | 481.43k |
| 52 Week Change | 17.68% |
| 52 Week High | 0.9099 |
| 52 Week Low | 0.2501 |
| Spread (Intraday) | 0.02 (4.36%) |
| Company Name | IGC Pharma Inc |
| Address |
2405 york road lutherville timonium, maryland 21093-2264 |
| Website | https://www.igcinc.us |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
